About
Chimeric Therapeutics Ltd (AU:CHM) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 21 2026
Minaris Delivers 100% Manufacturing and Release Success for Chimeric Therapeutics' CDH17 Autologous CAR‑T Program
Mar 19 2026
Consolidation/Split - CHM
Mar 2 2026
Chimeric receives $1.8 M advance on FY26 R&D tax incentive
Feb 27 2026
Half Year Report and Appendix 4D 31 December 2025
Feb 27 2026
Portfolio streamlined - return of CHM CLTX to City of Hope
Recent Videos
Chimeric Therapeutics (ASX: CHM) Presentation | NWR Virtual Healthcare Conference
Mar 24, 2026
Chimeric Therapeutics: Treating hard-to-crack solid tumours
Mar 04, 2026
Chimeric Therapeutics (ASX:CHM) is headed for the CAR-T 'Big Time'
Dec 11, 2025
Chimeric Therapeutics investor update webinar
Oct 09, 2025
Financials
Revenue
A$9.75 M
Market Cap
A$8.84 M
EPS
-0.01